Evidence map›Paper›PMID 35631302›Full record

SynthesisNutrients2022

Celiac Disease and Thrombotic Events: Systematic Review of Published Cases.

Nikola Pantic, Ivana Pantic, Dorde Jevtic, Vanajakshi Mogulla, Stevan Oluic, Momcilo Durdevic, Terri Nordin, Mladen Jecmenica, Tamara Milovanovic, Tatjana Gavrancic and 1 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Cardiomyopathy in Celiac Disease: A Systematic Review.Journal of clinical medicine · 2024
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Nikola PanticClinic of Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0001-7798-4026
Ivana PanticClinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0003-1137-1141
Dorde JevticElmhurst Hospital Center, Department of Internal Medicine, Elmhurst, NY 11373, USA.ORCID 0000-0003-3790-3951
Vanajakshi MogullaMayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.ORCID 0000-0002-4816-5256
Stevan OluicDepartment of Internal Medicine, Loyola University Medical Center, Maywood, IL 60153, USA.
Momcilo DurdevicDepartment of Hospital Medicine, Advocate Aurora Health, Green Bay, WI 54311, USA.ORCID 0000-0002-5196-3267
Terri NordinMayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.
Mladen JecmenicaOceana Gastroenterology Associated, Corona, CA 92881, USA.ORCID 0000-0002-6866-2049
Tamara MilovanovicClinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Tatjana GavrancicDepartment of Hospital Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
Igor DumicMayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.ORCID 0000-0002-5312-8812
Mayo Clinic Health System · USAurora Health Care · USElmhurst Hospital Center · USLoyola University Medical Center · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extraintestinal manifestations of celiac disease (CD) should be considered, even in patients without typical intestinal symptoms. The aim of our study is to examine the literature regarding the occurrence of thrombotic events in CD, and to synthesize the data from case reports and case series. A systematic review of the literature was conducted by searching the Pub-Med/MEDLINE database, from the date of database inception to January 2022, to identify published cases and case series on this topic, in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A total of 55 cases were included in the study. The majority of patients were previously healthy individuals, with no comorbidities. In less than one-third of the cases (30.91%), the diagnosis of CD was established before the onset of thrombosis, while in the remaining cases (34.54%), thrombosis preceded the diagnosis or was diagnosed concomitantly with CD. The most common sites for thrombosis occurrence were hepatic veins (30.91%), while thrombosis of cerebral blood vessels, deep venous thrombosis of lower extremities, and pulmonary thromboembolism were less frequent. Thrombosis was most commonly isolated to one site only (78.18%). In 69.09% of cases (

Indexed as

Celiac DiseasePulmonary EmbolismThrombosisHumansLower ExtremityPublicationsceliac diseaseextraintestinal celiac manifestationsgluten-sensitive enteropathyhypercoagulabilitythromboembolismthrombosisthrombotic events

Identifiers

PMID35631302
PMCPMC9144428
OpenAlexW4281384849

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.